logo
ProjectEnded

Drug repurposing and discovery multidisciplinary training network

Sector: Education • Location: Netherlands, Belgium, Spain, Germany, Sweden, United Kingdom

Source: EU Funding & Tenders Portal

Drug repurposing (or repositioning) is the application of previously identified drugs or compounds to treat new indications. The International Rare Diseases Research Consortium (IRDiRC) set as main goal for 2027 that 1000 new therapies for rare diseases will be approved. One of the levers to achieve this goal includes the repurposing of already existing and marketed drugs. In this context, DRUGtra

Status
Closed
Sector
Education, Hospital
Location
Netherlands
Updated
22 Jul 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about Drug repurposing and discovery multidisciplinary training network

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Drug repurposing and discovery multidisciplinary training network” is an infrastructure initiative in the Education sector, located in Netherlands, Belgium, Spain, Germany, Sweden, United Kingdom. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

ended

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Drug repurposing (or repositioning) is the application of previously identified drugs or compounds to treat new indications. The International Rare Diseases Research Consortium (IRDiRC) set as main goal for 2027 that 1000 new therapies for rare diseases will be approved. One of the levers to achieve this goal includes the repurposing of already existing and marketed drugs. In this context, DRUGtrain offers a timely paradigm for multidisciplinary research ideal for improving drug repurposing and development strategies of compounds, with Autosomal Dominant Polycystic Kidney Disease (ADPKD) as example. Identifying compounds for repurposing requires a broad variety of approaches. Therefore, the aim of DRUGtrain is to offer a multidisciplinary research training program to young researchers preparing them to become leading scientists able to integrate molecular and pharmacological data, and translate fundamental research questions to the (pre)clinic and vice versa. The research objectives of DRUGtrain are: 1) To identify potential drug targets and drug candidates for repurposing using innovative bio-informatics and cheminformatics approaches; 2) To perform drug testing/drug screenings in advanced in vitro and in vivo models, ultimately leading to testing of new treatment strategies; 3) To clarify drug mechanisms, and identify and reduce adverse events using state-of-the-art technologies from in silico and wet lab methodologies. Complementary training through courses will cover additional topics in drug repurposing and drug discovery as well as scientific skills, personal development, commerce and entrepreneurship. In DRUGtrain, 6 academic and 4 private sector beneficiaries/partner organisations and 1 NGO are collaborating in joining forces to intensify network activities between academia, industry, and a patient organization. The training offered should support the ESRs in becoming the next generation of true multidisciplinary researchers in (bio)pharmaceutical sciences.

Location

Country

Netherlands

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Education, Hospital

Article published date

2026-03-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project